CMDA
CMDA is a prodrug that can release cytotoxic molecules under the action of CPG2. CMDA can be used for cancer research[1].
Product Specifications
CAS Number
[122665-73-0]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Drug Metabolite
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
CS(OCCN(C1=CC=C(C(N[C@H](C(O)=O)CCC(O)=O)=O)C=C1)CCCl)(=O)=O
Molecular Formula
C17H23ClN2O8S
Molecular Weight
450.89
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Yu T, et al. Development of ZD2767P-carboxypeptidase G2-ultrasound therapy against cisplatin-resistant cancer. Front Oncol. 2023 May 18;13:1151613.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
